Analystreport

Fennec Pharmaceuticals Inc (NASDAQ: FENC) was downgraded by analysts at Cantor Fitzgerald from an "overweight" rating to a "neutral" rating.

Fennec Pharmaceuticals Inc.  (FENC) 
Last fennec pharmaceuticals inc. earnings: 11/12 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.fennecpharma.com/investor-relations